The study is conducted on a healthy population, focusing on perceived stress, emotional self-awareness, and self-efficacy.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Medical interns and externs enrolled at Kurdistan University of Medical Sciences Willingness to participate and providing written informed consent Access to a computer or smartphone to use the digital intervention platform
Exclusion criteria
Exclusion criteria: Presence of untreated or uncontrolled psychiatric disorders Diagnosis of alcohol or substance use disorders based on DSM-5 criteria Presence of chronic medical conditions or malignancies that could interfere with study participation Inability to complete the digital questionnaires or perform the required exercises
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Participants' perceived stress score will be measured using the Perceived Stress Scale (Cohen et al., 1983), which includes 16 items rated on a 5-point Likert scale (0 to 4). This score reflects the individual's subjective stress level in response to daily situations and will be assessed at baseline and post-intervention. A change of more than half a standard deviation from the baseline will be considered a meaningful change. Timepoint: Measurement Time Points (English):Baseline: Before the start of the intervention.Post-Intervention: Immediately after the intervention period (Week 6–8).Follow-Up (if applicable): 4 weeks after the intervention for monitoring long-term effects. Method of measurement: Perceived Stress: Evaluated using the Perceived Stress Scale by Cohen et al., comprising 14 items rated on a five-point Likert scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Participants' self-efficacy score measured using the General Self-Efficacy Scale (Schwarzer & Jerusalem, 1981), consisting of 10 items on a 4-point Likert scale (1 to 4). This score assesses the perceived ability to cope with challenges and will be evaluated before and after the intervention. In the final analysis, an increase of more than half a standard deviation from baseline will be considered a meaningful improvement in self-efficacy. Timepoint: Baseline: Before the start of the intervention.Post-Intervention: Immediately after the intervention period (Week 6–8).Follow-Up (if applicable): 4 weeks after the intervention for monitoring long-term effects. Method of measurement: Self-Efficacy: Assessed using the General Self-Efficacy Questionnaire by Jerusalem and Schwarzer (Persian version), containing 10 items rated on a four-point scale.;Participants' emotional self-awareness score will be assessed using the Emotional Self-Awareness Questionnaire by Grant et al. (2002), consisting of 33 items on a 5-point Likert scale (1 to 5). This score measures the ability to identify, understand, and process emotions. It will be measured before and after the intervention. An increase of more than half a standard deviation from baseline will be considered a meaningful improvement. Timepoint: Baseline: Before the start of the intervention.Post-Intervention: Immediately after the intervention period (Week 6–8).Follow-Up (if applicable): 4 weeks after the intervention for monitoring long-term effects. Method of measurement: Emotional Self-Awareness: Measured using the Emotional Self-Awareness Questionnaire developed by Grant et al., consisting of 33 items rated on a five-point Likert scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Sanandaj University of Medical Sciences